Immunotherapy of SARS based on combinations of neutralizing human monoclonal antibodies

Evaluation of: Coughlin MM, Babcook J, Prabhakar BS: Human monoclonal antibodies to SARS-coronavirus inhibit infection by different mechanisms. Virology 394(1), 39–46 (2009). This work discusses passive immunotherapy based on neutralizing human monoclonal antibodies (mAbs) with different mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Lanying, Jiang, Shibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2010
Materias:
Priority Paper Evaluation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079818/
https://www.ncbi.nlm.nih.gov/pubmed/32201501
http://dx.doi.org/10.2217/fvl.09.78

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079818/
https://www.ncbi.nlm.nih.gov/pubmed/32201501
http://dx.doi.org/10.2217/fvl.09.78

Ejemplares similares